EyePoint Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
EYPT
CUSIP
30233G209
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 162 74.1 M $402 M
2024 Q4 154 74.4 M $553 M
2024 Q3 148 58.9 M $479 M
2024 Q2 165 60.9 M $530 M
2024 Q1 181 57.9 M $1.20 B
2023 Q4 163 52.1 M $1.20 B
2023 Q3 111 33.7 M $270 M
2023 Q2 88 31.6 M $275 M
2023 Q1 71 29.1 M $85.6 M
2022 Q4 82 29.8 M $104 M
2022 Q3 92 31.5 M $250 M
2022 Q2 88 30.2 M $238 M
2022 Q1 89 30.4 M $370 M
2021 Q4 99 29.8 M $365 M
2021 Q3 70 22.1 M $231 M
2021 Q2 68 20.7 M $186 M
2021 Q1 67 19.6 M $200 M
2020 Q4 35 7.70 M $50.7 M